GenMark Diagnostics to Present at Two Upcoming Investor Conferences

• Raymond James’ 36th Annual Institutional Investors Conference on March 2, 2015
• Cowen and Company’s 35th Annual Health Care Conference on March 4, 2015

GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the Raymond James 36th Annual Institutional Investors Conference to be held at the JW Marriott Grande Lakes in Orlando, Florida on Monday, March 2, 2015 at 2:50 pm Eastern Time. Mr. Massarany will also present at the Cowen and Company 35th Annual Health Care Conference to be held at the Boston Marriott Copley Place in Boston, Massachusetts on Wednesday, March 4, 2015, at 9:20 am Eastern Time.

The presentation will be made available at http://ir.genmarkdx.com.

ABOUT GENMARK DIAGNOSTICS

GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark’s eSensor XT-8TM system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor detection technology is also incorporated into GenMark’s sample-to-answer system, ePlexTM. For more information, visit www.genmarkdx.com.

GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief Executive Officer760-448-4358